Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Accenture
Dow
US Department of Justice
Boehringer Ingelheim
Covington
Queensland Health
Mallinckrodt
Healthtrust

Generated: April 25, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020723

« Back to Dashboard

NDA 020723 describes ALDARA, which is a drug marketed by Medicis and is included in one NDA. It is available from one supplier. There is one patent protecting this drug and one Paragraph IV challenge. Additional details are available on the ALDARA profile page.

The generic ingredient in ALDARA is imiquimod. There are fourteen drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the imiquimod profile page.
Summary for 020723
Tradename:ALDARA
Applicant:Medicis
Ingredient:imiquimod
Patents:1
Therapeutic Class:Dermatological Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 020723
Suppliers and Packaging for NDA: 020723
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ALDARA imiquimod CREAM;TOPICAL 020723 NDA Valeant Pharmaceuticals North America LLC 99207-260 N 99207-260-12

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CREAM;TOPICALStrength5%
Approval Date:Feb 27, 1997TE:ABRLD:Yes
Patent:➤ Try a Free TrialPatent Expiration:Oct 1, 2024Product Flag?Substance Flag?Delist Request?Y

Expired US Patents for NDA 020723

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Medicis ALDARA imiquimod CREAM;TOPICAL 020723-001 Feb 27, 1997 ➤ Try a Free Trial ➤ Try a Free Trial
Medicis ALDARA imiquimod CREAM;TOPICAL 020723-001 Feb 27, 1997 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
US Army
Dow
US Department of Justice
UBS
Mallinckrodt
Chinese Patent Office
Queensland Health
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.